Markus Mittnenzweig wins ERC Starting Grant
How does a single cell know to become a heart, a muscle, or a neuron? The mystery of how life unfolds from a single cell into a complex, functioning organism has long fascinated biologists. For Dr. Markus Mittnenzweig, Group Leader of the Computational and developmental biology lab at the Max Delbrück Center, the question is more than just a matter of wonder – it is the focus of his career.
Now, with a prestigious European Research Council (ERC) Starting Grant of €1.5 million awarded over five years, Mittnenzweig will use a combination of technologies to understand the ballet of signals and spatial cues that nudge zebrafish embryos to develop specialized tissues and organs.
“We can now measure and quantify many different layers of gene regulation and chart the transition from a mass of pluripotent cells – capable of becoming anything – into the explosion of diverse cell types that make up an embryo,” says Mittnenzweig.
From the moment a fertilized egg begins to divide, the process of cellular differentiation transforms multi-purpose cells into specialists. Choreographed by shifting gene activity and other factors, once-pluripotent cells gradually commit to becoming muscle, blood, neurons, or myriad other tissue types. This transition is neither random nor linear – it is a tightly timed dialogue between the cell’s own genetic program and the cues it receives from its neighbors. Making deciphering this dynamic even more complex, the same signaling molecule can have multiple tasks – a single molecular cue can push one cell toward becoming a neuron while steering another toward blood, for example, depending on when it is expressed and the context.
Opening a new frontier
Markus Mittnenzweig
Mittnenzweig will combine single-cell RNA sequencing with cell lineage tracing and spatial transcriptomics among other technologies to collect data from early stage zebrafish embryos as they develop over time. Using computational tools developed in his lab, he will analyze the data to create maps of which genes switch on or off, at what precise times and and of the communication among neighboring cells. He aims to then feed these maps into mathematical models to predict how a cell’s genetic and chemical signals influence its future behavior, and then run systematic experiments to test these predictions.
“We want to understand how these dynamics unfold in real time,” Mittnenzweig explains. By quantifying gene expression of cells in a spatial context, his models will reveal how networks of interacting cells orchestrate development. Moreover, he aims to reconstruct such cellular dynamics in 3D.
“Ten years ago, we couldn’t quantify the regulation of these processes in a spatial context at the single-cell level,” he says. “Now we can, and it will open an entirely new frontier.”
Text: Gunjan Sinha
Further information
- ERC Starting Grants
- ERC press release
- The modeler of cell development: Profile on Markus Mittnenzweig
- ERC grants at the Max Delbrück Center
Contacts
Dr. Markus Mittnenzweig
Group Leader, Computational and developmental biology
Berlin Institute for Medical Systems Biology of the Max Delbrück Center (MDC-BIMSB)
markus.mittnenzweig@mdc-berlin.de
Jana Schlütter
Editor, Communications
Max Delbrück Center
+49 30 9406-2121
jana.schluetter@mdc-berlin.de or presse@mdc-berlin.de
- Max Delbrück Center
The Max Delbrück Center for Molecular Medicine in the Helmholtz Association lays the foundation for the medicine of tomorrow through our discoveries of today. At locations in Berlin-Buch, Berlin-Mitte, Heidelberg, and Mannheim, interdisciplinary teams investigate the complexity of disease at the systems level – from molecules and cells to organs and entire organisms. Together with academic, clinical, and industry partners, and as part of global networks, we turn biological insights into innovations for early detection, personalized therapies, and disease prevention. Founded in 1992, the Max Delbrück Center is home to a vibrant, international research community of around 1,800 people from over 70 countries. We are 90 percent funded by the German federal government and 10 percent by the state of Berlin.